Veru (VERU) News Today $0.50 -0.01 (-1.55%) Closing price 04:00 PM EasternExtended Trading$0.50 0.00 (-0.22%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Veru (VERU) Projected to Post Quarterly Earnings on ThursdayVeru (NASDAQ:VERU) will be releasing its Q2 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-veru-inc-stock/)May 4 at 10:23 AM | marketbeat.comAdage Capital Partners GP L.L.C. Has $1.50 Million Stock Holdings in Veru Inc. (NASDAQ:VERU)Adage Capital Partners GP L.L.C. reduced its holdings in shares of Veru Inc. (NASDAQ:VERU - Free Report) by 70.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,300,000 shares of the company's stock after selliMay 2, 2025 | marketbeat.comVeru to Report Fiscal 2025 Second Quarter Financial Results on May 8May 1, 2025 | globenewswire.comVeru to Present at the 2nd Annual GLP-1-Based Therapeutics SummitApril 16, 2025 | globenewswire.comVeru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation ConferenceMarch 31, 2025 | globenewswire.comUnusually active option classes on open March 25thMarch 25, 2025 | markets.businessinsider.comVeru Sees Unusually High Options Volume (NASDAQ:VERU)Veru Inc. (NASDAQ:VERU - Get Free Report) saw unusually large options trading on Monday. Stock investors acquired 9,142 call options on the stock. This is an increase of 206% compared to the typical daily volume of 2,983 call options.March 18, 2025 | marketbeat.comVeru Inc. Shareholders Approve Equity Plan AmendmentMarch 14, 2025 | tipranks.comHere's Why Veru (VERU) Looks Ripe for Bottom FishingMarch 12, 2025 | msn.comVeru Inc. (NASDAQ:VERU) Holdings Raised by Oppenheimer & Co. Inc.Oppenheimer & Co. Inc. grew its position in Veru Inc. (NASDAQ:VERU - Free Report) by 181.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,120,586 shares of the company's stock after acquiring an additional 722,644 sharesMarch 6, 2025 | marketbeat.comInsider Buying: Veru Inc. (NASDAQ:VERU) Director Purchases 95,279 Shares of StockVeru Inc. (NASDAQ:VERU - Get Free Report) Director Michael L. Rankowitz bought 95,279 shares of the company's stock in a transaction on Tuesday, February 18th. The stock was bought at an average price of $0.55 per share, with a total value of $52,403.45. Following the completion of the acquisition, the director now owns 195,279 shares in the company, valued at $107,403.45. This represents a 95.28 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.February 21, 2025 | marketbeat.comVeru Inc. (NASDAQ:VERU) Director Michael L. Rankowitz Purchases 95,279 SharesFebruary 21, 2025 | insidertrades.comFocus: Next generation weight loss drugs aim to save muscleFebruary 19, 2025 | reuters.comNew weight loss drugs aim to promote muscle growthFebruary 19, 2025 | msn.comVeru Inc. (NASDAQ:VERU) Short Interest Up 14.3% in JanuaryVeru Inc. (NASDAQ:VERU - Get Free Report) saw a large growth in short interest in January. As of January 31st, there was short interest totalling 14,620,000 shares, a growth of 14.3% from the January 15th total of 12,790,000 shares. Based on an average daily volume of 2,950,000 shares, the short-interest ratio is currently 5.0 days.February 16, 2025 | marketbeat.comVeru Inc. (NASDAQ:VERU) Q1 2025 Earnings Call TranscriptFebruary 14, 2025 | msn.comVeru: Discussions on tariffs are negotiation means to an endFebruary 14, 2025 | msn.comVeru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ...February 14, 2025 | finance.yahoo.comVeru targets Phase 3 enobosarm trials following promising Phase 2b results in obesity treatmentFebruary 13, 2025 | msn.comVeru Inc (VERU) Q1 2025 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comVeru (NASDAQ:VERU) Issues Earnings ResultsVeru (NASDAQ:VERU - Get Free Report) released its earnings results on Thursday. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.01. Veru had a negative return on equity of 92.88% and a negative net margin of 223.85%.February 13, 2025 | marketbeat.comVeru Inc.: Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program ProgressFebruary 13, 2025 | finanznachrichten.deVeru reports Q1 cont-op EPS (1c) vs. (8c) last yearFebruary 13, 2025 | markets.businessinsider.comEarnings call transcript: Veru Inc Q1 2025 beats EPS forecast, stock dipsFebruary 13, 2025 | msn.comVeru (NASDAQ:VERU) Announces Quarterly Earnings ResultsVeru (NASDAQ:VERU - Get Free Report) released its earnings results on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.01. Veru had a negative return on equity of 92.88% and a negative net margin of 223.85%.February 13, 2025 | marketbeat.comVeru Inc. Reports Positive Phase 2b QUALITY Study Results and Announces New Indication for Sabizabulin in Atherosclerotic Coronary Artery DiseaseFebruary 13, 2025 | quiverquant.comVeru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program ProgressFebruary 13, 2025 | globenewswire.comADAGE CAPITAL PARTNERS GP, L.L.C. Reduces Stake in Veru Inc.February 12, 2025 | gurufocus.comVeru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | finance.yahoo.comVeru (VERU) Projected to Post Earnings on ThursdayVeru (NASDAQ:VERU) will be releasing earnings before the market opens on Thursday, February 6, Financial Modeling Prep reports.February 4, 2025 | marketbeat.comVeru (VERU) to Release Quarterly Earnings on ThursdayVeru (NASDAQ:VERU) will be releasing earnings before the market opens on Thursday, February 6, Financial Modeling Prep reports.January 30, 2025 | marketbeat.comVeru Inc.’s Promising Phase IIb Results Suggest Investment Opportunity with Enobosarm’s Weight Management PotentialJanuary 28, 2025 | markets.businessinsider.comVeru’s enobosarm meets primary endpoint in Phase 2b weight reduction trialJanuary 27, 2025 | markets.businessinsider.comOppenheimer maintains Veru stock Outperform rating, $5 targetJanuary 27, 2025 | msn.comVeru Shares Tumble Despite Enobosarm's Lean Muscle Preservation BreakthroughJanuary 27, 2025 | benzinga.comVeru's experimental drug helps Wegovy patients preserve muscle in studyJanuary 27, 2025 | reuters.comVeru's drug helps older Wegovy patients preserve muscle in studyJanuary 27, 2025 | msn.comVeru Reports Positive Data From Phase 2b QUALITY StudyJanuary 27, 2025 | markets.businessinsider.comVeru's experimental drug helps older obese patients on Wegovy preserve muscleJanuary 27, 2025 | msn.comVeru Inc. Reports Positive Topline Results from Phase 2b QUALITY Study of Enobosarm in Combination with WEGOVY for Lean Mass Preservation in Older Patients with ObesityJanuary 27, 2025 | quiverquant.comVeru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight ReductionJanuary 27, 2025 | globenewswire.comOppenheimer maintains Veru stock Outperform rating as trial nearsJanuary 24, 2025 | msn.comInvestors Purchase High Volume of Veru Call Options (NASDAQ:VERU)Veru Inc. (NASDAQ:VERU - Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock traders acquired 8,511 call options on the stock. This represents an increase of 500% compared to the average daily volume of 1,418 call options.January 22, 2025 | marketbeat.comStock Traders Purchase Large Volume of Veru Call Options (NASDAQ:VERU)Veru Inc. (NASDAQ:VERU - Get Free Report) saw some unusual options trading activity on Tuesday. Stock investors bought 8,511 call options on the stock. This represents an increase of 500% compared to the typical daily volume of 1,418 call options.January 21, 2025 | marketbeat.comCharity single raising awareness of Bedfordshire VERU’s #justdropit campaign recognised by Northampton Film FestivalJanuary 16, 2025 | msn.comWhat is B. Riley's Forecast for Veru Q1 Earnings?Veru Inc. (NASDAQ:VERU - Free Report) - B. Riley issued their Q1 2025 earnings per share estimates for Veru in a research note issued to investors on Thursday, January 9th. B. Riley analyst W. Wood anticipates that the company will post earnings per share of ($0.08) for the quarter. The consensusJanuary 13, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Veru (VERU)January 12, 2025 | markets.businessinsider.comVeru Inc. Sells FC2 Business to Focus on BiopharmaJanuary 3, 2025 | tipranks.comVeru's (VERU) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $3.00 price target on shares of Veru in a report on Thursday.January 2, 2025 | marketbeat.comVeru Inc.: Veru Announces the Sale of the FC2 Female Condom (Internal Condom) BusinessJanuary 1, 2025 | finanznachrichten.de Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address VERU Media Mentions By Week VERU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERU News Sentiment▼0.560.69▲Average Medical News Sentiment VERU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERU Articles This Week▼32▲VERU Articles Average Week Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NUS News NATR News MED News EL News PBH News IPAR News HLF News USNA News ATAI News CYRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VERU) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VERU Stock Free VERU Stock Alerts